Atopica for Cats Oral Solution 100 mg/mL (cyclosporine oral solution, USP) Modified is a new way to treat an "itcy" cat. Available in 2 sizes: 5 mL and 17 mL.Atopica for Cats (cyclosporine capsules,USP) MODIFIEDis indicated for the control of feline allergic dermatitis as manifested by excoriations (including facial and neck), miliary dermatitis, eosinophilic plaques, and self-induced alopecia in cats at least 6 months of age and at least 3 lbs (1.4 kg) in body weight.
Dosage and Administration The initial dose of ATOPICA for Cats is 3.2 mg/lb/day (7 mg/kg/day) as a single daily dose for a minimum of 4 to 6 weeks or until resolution of clinical signs. Following this initial daily treatment period, the dose of ATOPICA for Cats may be tapered by decreasing the frequency of dosing to every other day or twice weekly to maintain the desired therapeutic effect. ATOPICA for Cats should be administered directly on a small amount of food or orally just after feeding. Whenever possible, ATOPICA for Cats should be administered on a consistent schedule with regard to meals and time of day. If a dose is missed, the next dose should be administered (without doubling) as soon as possible, but dosing should be no more frequent than once daily.
The dispensing system includes an oral dosing syringe graduated in
1 lb increments. To dose the cat, the syringe should be filled to the
nearest 1 lb corresponding to the cat’s body weight (round down if
0.1 to 0.4 lb, round up if 0.5 to 0.9 lb). Each pound graduation on the
syringe delivers a volume of 0.032 mL providing 3.2 mg/lb. Do not
rinse or clean the oral dosing syringe between uses. (See Instructions for Assembling the Dispensing System and Preparing a Dose
of ATOPICA for Cats)|
Storage Conditions: ATOPICA for Cats should only be dispensed in the original container and stored at controlled room temperature between 59 and 77°F (15- 25°C). Once opened, use contents within two months for the 5 mL container and 11 weeks for the 17 mL container.
WARNINGS: ATOPICA for Cats is a systemic immunosuppressant that may increase the susceptibility to infection and the development of neoplasia. One of 205 field study cats died of the effusive form of feline infectious peritonitis.